Sotabase

Career

· CEO and Co-Founder, Bluefish AI2024–
· Angel Investor, Bastille Capital2021–
· Founder and General Manager of Microsoft-PromoteIQ, Microsoft2019–2022
· CEO and Co-Founder, PromoteIQ2012–2022
· Product Manager, MediaMath2009–2012
· BA in History, Columbia University in the City of New York2005–2008

Publications (53)

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene in and for Therapeutic
2018
367
cited
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
New England Journal of Medicine · 2020
359
cited
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression
Nature Biotechnology · 2014
200
cited
Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial
Lancet Neurology · 2014
187
cited
The PRO-ACT database
Neurology · 2014
156
cited
Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis
Muscle and Nerve · 2020
135
cited
Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines
Nature Neuroscience · 2020
124
cited
How common are ALS plateaus and reversals?
Neurology · 2016
88
cited
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS
Amyotrophic Lateral Sclerosis · 2012
88
cited
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development
Annals of Neurology · 2021
69
cited
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Journal of Neurology Neurosurgery & Psychiatry · 2022
57
cited
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?
Neurotherapeutics · 2015
44
cited
Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data
Nature Computational Science · 2022
44
cited
Urate levels predict survival in amyotrophic lateral sclerosis: Analysis of the expanded Pooled Resource Open‐Access ALS clinical trials database
Muscle and Nerve · 2018
40
cited
Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis
Annals of Neurology · 2023
32
cited
Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers
Neurology · 2019
32
cited
Investigating the Utility of Multimodal Conversational Technology and Audiovisual Analytic Measures for the Assessment and Monitoring of Amyotrophic Lateral Sclerosis at Scale
Interspeech · 2021
31
cited
Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS).
Journal of Neurology & Neurophysiology · 2017
28
cited
ALS Untangled No. 20: The Deanna Protocol
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2013
21
cited
Amyotrophic Lateral Sclerosis: An Emerging Era of Collaborative Gene Discovery
PLoS ONE · 2007
19
cited
Sotabase
Alex Sherman | Researcher Profile | Sotabase | Sotabase